Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$397.50 USD

397.50
1,388,392

-5.93 (-1.47%)

Updated Sep 17, 2024 04:00 PM ET

After-Market: $397.50 0.00 (0.00%) 6:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (3 out of 251)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Healthcare Stock Earnings Slated on Oct 29: HCA, MOH & More

by Zacks Equity Research

Increasing demands for products and services are likely to have driven earnings for players in the healthcare industry.

HCA Healthcare (HCA) to Post Q3 Earnings: What to Expect

by Zacks Equity Research

HCA Healthcare's (HCA) third-quarter results are likely to reflect elevated expenses, partly offset by higher topline from increase in admissions and licensed beds.

Sumit Singh headshot

Add These 5 Stocks With Amazing Interest Coverage Ratio

by Sumit Singh

Interest coverage ratio is used to determine how effectively a company can pay the interest charged on its debt.

Humana to Provide Florida's Retirees With Medicare Plans

by Zacks Equity Research

Humana's (HUM) Medicare plans to help the State of Florida Medicare-eligible retirees and their eligible dependents achieve better health outcomes.

MEDNAX (MD) to Sell MedData for Focusing on Core Business

by Zacks Equity Research

MEDNAX (MD) to divest its billing services business for streamlining its operations.

Will UnitedHealth's (UNH) Benefits Business Aid Q3 Earnings?

by Zacks Equity Research

Strength in UnitedHealth's (UNH) health service segment is likely to reflect in Q3 results.

Humana's New Plans to Complement VA Healthcare Coverage

by Zacks Equity Research

Humana's (HUM) Humana Honor Medicare Advantage plans to help veterans get better health outcomes. It will also complement the VA plan.

Centene's Carolina Complete Health Wins Medicaid Contract

by Zacks Equity Research

Centene's (CNC) provider-led North Carolina subsidiary clinches Medicaid contract to provide services in additional areas.

Humana's (HUM) Medicare Business Aids, High Costs Persist

by Zacks Equity Research

Humana's (HUM) revenues and membership gain on strong Medicare business. However, high expenses hurt.

Tenet Healthcare's Strategic Initiatives Aid, Revenues Drag

by Zacks Equity Research

Strategic divestitures bode well for Tenet Healthcare's (THC) growth. However, depleting revenues is a lingering woe.

Universal Health (UHS) Up 27.6% YTD: Will the Rally Continue?

by Zacks Equity Research

Universal Health (UHS) is poised to grow over the long term on the back of strong contribution from its segments and accretive acquisitions.

Sapna Bagaria headshot

Hospital Industry Outlook: Rising Baby Boomers to Drive Growth

by Sapna Bagaria

The Zacks Medical-Hospital industry is set to gain from demographic changes and growing consolidation amid high labor cost.

5 Factors That Make Acadia Healthcare Stock Look Unattractive

by Zacks Equity Research

Rising expenses, underperforming U.K business and low guidance are a drag on Acadia Healthcare's (ACHC) stock.

Here's Why You Should Avoid Acadia Healthcare Stock Now

by Zacks Equity Research

Lack of clarity on the sale of its underperforming U.K. business continues to hurt Acadia Healthcare (ACHC).

HCA (HCA) Down 10.8% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Can Value Investors Consider HCA Healthcare (HCA) Stock?

by Zacks Equity Research

HCA Healthcare (HCA) stock may be a good choice for value-oriented investors right now from multiple angles.

David Borun headshot

Trade and Currency Concerns Put Pressure on Equities

by David Borun

A busy week of data and a Fed meeting was dominated by China trade issues

Is HCA Healthcare (HCA) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (HCA) Outperforming Other Medical Stocks This Year?

HCA Healthcare (HCA) Q2 Earnings and Revenues Lag Estimates

by Zacks Equity Research

HCA Healthcare's (HCA) second-quarter earnings decline due to escalating expenses.

HCA Healthcare's (HCA) Q2 Earnings Miss Estimates, Down Y/Y

by Zacks Equity Research

HCA Healthcare's (HCA) second quarter earnings suffer from elevated expenses.

Is HCA Holdings (HCA) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Magellan Health (MGLN) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

Magellan Health (MGLN) is likely to benefit from its Healthcare segment, partly offset by rise in expenses.

What's in the Cards for HCA Healthcare's (HCA) Q2 Earnings?

by Zacks Equity Research

HCA Healthcare's (HCA) Q2 earnings are likely to be aided by higher admissions and revenues, partly offset by escalating expenses.

Will HCA (HCA) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

HCA Holdings (HCA) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.